⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,840.86
−0.18%
FTSE ADX
9,837.44
+0.55%
TASI
10,099.02
−0.24%
QE Index
8,566.91
−0.76%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
166,126.86
+0.10%
DFM:EMIRATESNBD
AED 31.54
+0.13%
ADX:IHC
AED 357.20
+1.48%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.49
−1.09%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.64
+0.06%
Gold
$4,128.97
−0.29%
Brent
$110.34
+1.03%
BTC
$81,613.04
−0.28%
ETH
$2,392.01
−0.55%
DFM General
5,840.86
−0.18%
FTSE ADX
9,837.44
+0.55%
TASI
10,099.02
−0.24%
QE Index
8,566.91
−0.76%
S&P 500
7,690.73
+0.41%
Nasdaq 100
29,529.34
+1.17%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
166,126.86
+0.10%
DFM:EMIRATESNBD
AED 31.54
+0.13%
ADX:IHC
AED 357.20
+1.48%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.49
−1.09%
NAS:NVDA
$217.09
+1.38%
NYSE:TSM
$420.22
+1.84%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.64
+0.06%
Gold
$4,128.97
−0.29%
Brent
$110.34
+1.03%
BTC
$81,613.04
−0.28%
ETH
$2,392.01
−0.55%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Open
🇸🇦
Saudi Arabia
Tadawul · TASI
Open
🇶🇦
Qatar
QSE · QE General
Open
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Closed
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Open
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NAS
› SMMT
S
Summit Therapeutics Inc
NAS:SMMT
Healthcare
NASDAQ:NBI
NASDAQ:NQUSMG
—
—
At close · Market cap
—
· Next earnings
Wed 11 Nov
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
Summit Therapeutics Inc · News · TradingHolo
SMMT news
Headlines tagged to this company
SE
Catalyst Watch: Meta earnings, Kroger event, and Black Monday turns 39
Seeking Alpha · 4 d ago
SE
AstraZeneca inks AI drug discovery deal worth up to $1.5B with insitro
Seeking Alpha · 5 d ago
LO
REG - AstraZeneca PLC - AstraZeneca completes equity investment in Summit
London Stock Exchange · 15 d ago
BU
AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics
BusinessWire · 15 d ago
TR
Summit Therapeutics Inc. (SMMT) Closes $2B Equity Investment From AstraZeneca
TradingView · 15 d ago
SE
Trending stocks this week as markets weigh jobs data, yields
Seeking Alpha · 16 d ago
GU
AstraZeneca Stocks Moves Lower as Datroway Combination Enters Phase 3
GuruFocus · 18 d ago
RE
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination
Reuters · 18 d ago
RE
Mergers and acquisitions
Reuters · 18 d ago
SH
Weekly review
ShareCast · 18 d ago
ST
Summit Teams Up With Daiichi Sankyo, AstraZeneca For Cancer Therapy Trial – CEO Calls It An ‘Important Expansion’
Stocktwits · 18 d ago
RE
Major drugmakers turn to China for licensing deals
Reuters · 18 d ago
SE
AstraZeneca, Daiichi Sankyo collaborate with Summit Therapeutics to evaluate Datroway-ivonescimab combo
Seeking Alpha · 18 d ago
RE
AstraZeneca & Daiichi Sankyo announce clinical collaboration with Summit Therapeutics
Reuters · 18 d ago
BU
Daiichi Sankyo and AstraZeneca Enter into Clinical Trial Collaboration with Summit Therapeutics to Evaluate Datroway® in Combination with Ivonescimab Across Multiple Tumor Types
BusinessWire · 18 d ago
LO
REG - AstraZeneca PLC - AZ & DS collaboration with Summit for Datroway
London Stock Exchange · 18 d ago
BU
Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway
BusinessWire · 18 d ago
TR
Summit Therapeutics Inc. (SMMT) Sets AZ/Daiichi Trial Pact on Ivonescimab+Datroway
TradingView · 18 d ago
More news →